Yunhua Xu Selected Research

Phosphatidylinositol-4-Phosphate 3-Kinase

1/2018

Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunhua Xu Research Topics

Disease

13	Neoplasms (Cancer) 05/2022 - 01/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2014
5	Lung Neoplasms (Lung Cancer) 05/2020 - 08/2014
4	Adenocarcinoma of Lung 01/2022 - 01/2015
2	Neoplasm Metastasis (Metastasis) 07/2020 - 01/2015
2	Thrombocytopenia (Thrombopenia) 11/2019 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 01/2015 - 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	Adenocarcinoma 10/2022
1	Esophageal Squamous Cell Carcinoma 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Infections 10/2020
1	Necrosis 07/2020
1	Malignant Pleural Effusion 05/2020
1	Fever (Fevers) 05/2020
1	Pleural Effusion (Pleural Effusions) 05/2020
1	Chest Pain (Chest Pains) 05/2020
1	Carcinoma (Carcinomatosis) 11/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Cardiotoxicity 01/2018

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 09/2021 - 04/2017
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2014
2	Circular RNAIBA 01/2022 - 04/2021
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2015
1	Cetuximab (Erbitux)FDA Link 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	Cytidine Triphosphate (CTP)IBA 05/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2022
1	Lipid PeroxidesIBA 01/2022
1	IronIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2020
1	icotinibIBA 05/2020
1	Ethylene Glycol (Monoethylene Glycol)IBA 11/2019
1	GTP Phosphohydrolases (GTPases)IBA 11/2019
1	protein kinase PIBA 11/2019
1	Gemcitabine FDA Link 11/2019
1	Adenosine Monophosphate (AMP)IBA 11/2019
1	Interleukin-2 (IL2)IBA 11/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019
1	Thrombopoietin (c-mpl Ligand)IBA 11/2019
1	Carboplatin (JM8)FDA LinkGeneric 11/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2019
1	CrizotinibIBA 01/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018
1	oprelvekin (Neumega)FDA Link 01/2018
1	Phosphatidylinositol-4-Phosphate 3-KinaseIBA 01/2018
1	serum P-component (CIt)IBA 01/2018
1	osimertinibIBA 01/2018
1	ceritinibIBA 04/2017
1	saracatinibIBA 04/2017
1	Pemetrexed (MTA)FDA Link 01/2017
1	PlatinumIBA 01/2017
1	Pyruvate KinaseIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	CateninsIBA 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2015
1	Mitochondrial DNA (mtDNA)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Cytochromes c (Cytochrome c)IBA 01/2015
1	Polycomb-Group ProteinsIBA 08/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	AntioxidantsIBA 01/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013

Therapy/Procedure

6	Therapeutics 05/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 09/2021 - 01/2017
1	Adjuvant Chemotherapy 10/2022
1	Immunotherapy 03/2021
1	Aftercare (After-Treatment) 07/2020
1	Radiotherapy 07/2020
1	Pleurodesis 05/2020
1	Intraperitoneal Injections 11/2019
1	Subcutaneous Injections 11/2019